On December 30, 2025, Insilico Medicine, hailed as "the first AI-driven pharmaceutical stock on the Hong Kong stock market" and a strategic investment of the Hong Kong Investment Corporation Limited (HKIC), was listed on the Main Board of the Hong Kong Exchanges and Clearing Limited (HKEX). With a total fundraising of HK$2.277 billion, it has claimed the title of the largest IPO in the biopharmaceutical sector of the Hong Kong stock market in 2025, and its share price delivered an impressive performance on the debut day. It is reported that Biren Technology, another portfolio company of HKIC, is also set to list on the HKEX on January 2, 2026, which indicates that the effectiveness of HKIC’s diversified strategic investment layout continues to unfold.
On December 30,2025,NewTimeSpace,an AI-powered international financial media outlet,launched its English version.It provides bilingual (Chinese and English) financial information, covering niche areas such as IPOs and ETFs, and connects Chinese enterprises with global capital.
Knowledge Atlas(02513.HK) announced that it will conduct an IPO from December 30, 2025 to January 5, 2026, planning to globally offer 37.4195 million H shares, with an offer price of HK$116.20 per share. The H shares are expected to start trading on the Hong Kong Stock Exchange at 9:00 a.m. on January 8, 2026.
On December 30, 2025, Hong Kong's three major indices fluctuated and strengthened. The Hang Seng Index closed up 0.86%, the Hang Seng Tech Index rose 1.74%, and the Hang Seng China Enterprises Index climbed 1.12%. The total market trading volume reached HK$199.769 billion, with a net outflow of HK$3.845 billion in Southbound Capital.
